May 06, 2026

Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis

Caris MI Clarity leverages AI to transform how recurrence risk is understood and applied in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer IRVING, Texas, May 5, 2026 /PRNewswire/ -- Caris Life Sciences®...

recent articles

Press Release | VISTA, CA April 24, 2020 – Leica Biosystems, the global leader in pathology workflow solutions, today announced it has received additional notification from the U.S. Food & Drug Administration (FDA) about its intention to...

PRESS RELEASE: Expert Report calls for pathologists to engage hospital administrators to address key challenges and opportunities to improve cancer diagnostics and patient care London, UK – Apr. 23, 2020 – Leica Biosystems, a...

OR

platinum partners

gold partners

Silver Partners

Media Partners